Aaron M Wolfson

Clinical Assistant Professor of Medicine (Clinician Educator)

Image of Aaron M Wolfson
Is this your profile? Click to edit


Dr. Aaron M. Wolfson is an Advanced Heart Failure and Transplant Cardiologist and Clinical Assistant Professor of Medicine at Keck School of Medicine of the University of Southern California.

Dr. Wolfson graduated from Boston University College of Engineering where he earned a BS (2006) and MS (2008) in Biomedical Engineering. He stayed at the Boston University School of Medicine and earned his MD in 2012 having earned Alpha Omega Alpha (AOA) honors as a 4th year medical student.

He completed his internal medicine residency at University of Chicago, general cardiology fellowship at Los Angeles County + University of Southern California, and advanced heart failure and transplant cardiology fellowship at Cedars-Sinai Medical Center. Prior to joining Keck Medicine of USC in December of 2020, Dr. Wolfson was an Assistant Professor of Medicine at the University of Arizona in Tucson, Arizona.

He is board certified in internal medicine, cardiovascular medicine, advanced heart failure and transplant cardiology and echocardiography. In addition to taking care of patients that have undergone heart transplantation or implantation of a durable mechanical circulatory support device, he has an active outpatient clinic and cares for patients with all types of heart failure, heart valve diseases, coronary artery disease, hypertension and hyperlipidemia. He also performs right heart catheterizations, right ventricular endomyocardial biopsies and implants CardioMEMS pressure sensors for remote hemodynamic monitoring of heart failure patients.

His research has focused on remote hemodynamic monitoring in heart failure, temporary mechanical circulatory support and heart transplantation. He has a growing number of high-impact research manuscripts that have been published in the Journal of Heart and Lung Transplantation and the American Journal of Transplantation.


  • Southern California Magazine, Los Angeles Times: Southern California Rising Stars, Super Doctors, 2023
  • California Chapter of the American College of Cardiology: Excellence in Cardiology Fellowship Award, 2018
  • University of Chicago: University of Chicago Medicine Housestaff Teaching Award, 2015
  • Morton Arnsdorf Cardiovascular Research Symposium, University of Chicago: Featured Presentation in Clinical and Translational Science, 2014
  • National Medical Honor Society: Alpha Omega Alpha, 2012
  • National Engineering Honor Society: Tau Beta Pi, 2006
  • National Biomedical Engineering Honor Society: Alpha Eta Mu Beta, 2005


  • Accuracy and correlation of bed and standing scale weights in monitoring volume status in heart failure patients Future Cardiol. 2024 May 06. . View in PubMed
  • Successful Pregnancy After Left Ventricular Assist Device Explantation for Myocardial Recovery ASAIO J. 2024 Feb 01. . View in PubMed
  • New UNOS allocation system associated with no added benefit in waitlist outcomes and worse post-transplant survival in heart-kidney patients J Heart Lung Transplant. 2023 11; 42(11):1529-1542. . View in PubMed
  • Effect of the UNOS policy change on rates of rejection, infection, and hospital readmission following heart transplantation J Heart Lung Transplant. 2023 10; 42(10):1415-1424. . View in PubMed
  • Assessment of Aortic Characteristic Impedance and Arterial Compliance from Non-invasive Carotid Pressure Waveform in The Framingham Heart Study Am J Cardiol. 2023 10 01; 204:195-199. . View in PubMed
  • Effect of UNOS policy change and exception status request on outcomes in patients bridged to heart transplant with an intra-aortic balloon pump Artif Organs. 2022 May; 46(5):838-849. . View in PubMed
  • UNOS policy change benefits high-priority patients without harming those at low priority Am J Transplant. 2022 12; 22(12):2931-2941. . View in PubMed
  • Patient selection for heart transplant: balancing risk Curr Opin Organ Transplant. 2022 02 01; 27(1):36-44. . View in PubMed
  • Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation Circ Heart Fail. 2020 02; 13(2):e006696. . View in PubMed
  • Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality InitiativeJ Vasc Surg. 2019 10; 70(4):1225-1234. e1. . View in PubMed
  • A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management Cardiol Res Pract. 2019; 2019:7979830. . View in PubMed
  • Amyloid and the Heart Curr Cardiol Rep. 2019 12 03; 21(12):164. . View in PubMed
  • Chronic heart failure management and remote haemodynamic monitoring Heart. 2018 12; 104(23):1910-1919. . View in PubMed
  • Baseline diastolic pressure gradient and pressure reduction in chronic heart failure patients implanted with the CardioMEMS™ HF sensor ESC Heart Fail. 2018 06; 5(3):316-321. . View in PubMed
  • Editorial Commentary: The optimistic future of remote hemodynamic monitoring Trends Cardiovasc Med. 2018 04; 28(3):220-222. . View in PubMed
  • Pulmonary arterial pressure sensing in a patient with left ventricular assist device during ventricular arrhythmia HeartRhythm Case Rep. 2017 Jul; 3(7):348-351. . View in PubMed
  • Effects of pressure variation and atrial fibrillation on CardioMEMS™ HF measured pulmonary artery diastolic pressure: comparison of device-averaged and visually inspected waveforms Physiol Meas. 2017 Jun; 38(6):1094-1103. . View in PubMed